https://doi.org/10.15252/embj.2022111515
L
Lars Vereecke
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
126
Papers
5.7K
Citations
30
h-index
44
i10-index
Lars Vereecke is an academic researcher from Ghent University Hospital. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Gut microbiota and health & Immunotherapy and Immune Responses. The author has an h-index of 30, co-authored 108 publications.
ORCID: 0000-0002-1593-862XPapers by this author
worksGut microbiota regulates blood‐cerebrospinal fluid barrier function and Aβ pathology
2023 · The EMBO Journal · 104 citations
Colibactin-driven colon cancer requires adhesin-mediated epithelial binding
2024 · Nature · 49 citations
https://doi.org/10.1038/s41586-024-08135-z
Physical and functional interaction between A20 and ATG16L1-WD40 domain in the control of intestinal homeostasis
2019 · Nature Communications · 47 citations
https://doi.org/10.1038/s41467-019-09667-z
A guide to germ‐free and gnotobiotic mouse technology to study health and disease
2024 · FEBS Journal · 37 citations
https://doi.org/10.1111/febs.17124
Hepatic glutamine synthetase controls N5-methylglutamine in homeostasis and cancer
2022 · Nature Chemical Biology · 27 citations
https://doi.org/10.1038/s41589-022-01154-9
Ileal immune tonus is a prognosis marker of proximal colon cancer in mice and patients
2020 · Cell Death and Differentiation · 23 citations
https://doi.org/10.1038/s41418-020-00684-w
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat